CATAPRES- clonidine patch, extended release United States - English - NLM (National Library of Medicine)

catapres- clonidine patch, extended release

rebel distributors corp - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - clonidine 0.1 mg in 24 h - catapres-tts® (clonidine) transdermal therapeutic system is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. catapres-tts transdermal therapeutic system should not be used in patients with known hypersensitivity to clonidine or to any other component of the therapeutic system.

CATAPRES-TTS- clonidine patch United States - English - NLM (National Library of Medicine)

catapres-tts- clonidine patch

boehringer ingelheim pharmaceuticals inc. - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - clonidine 0.1 mg in 1 d - catapres‑tts transdermal therapeutic system is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. catapres‑tts transdermal therapeutic system should not be used in patients with known hypersensitivity to clonidine or to any other component of the therapeutic system.

CATAPRES TAB 0.1MG TABLET Canada - English - Health Canada

catapres tab 0.1mg tablet

boehringer ingelheim (canada) ltd ltee - clonidine hydrochloride - tablet - 0.1mg - clonidine hydrochloride 0.1mg - central alpha-agonists

CATAPRES TAB 0.2MG TABLET Canada - English - Health Canada

catapres tab 0.2mg tablet

boehringer ingelheim (canada) ltd ltee - clonidine hydrochloride - tablet - 0.2mg - clonidine hydrochloride 0.2mg - central alpha-agonists

CATAPRES TAB. 0.150 mg Egypt - English - EDA (Egyptian Drug Authority)

catapres tab. 0.150 mg

boehringer ingelheim sceintific office - tablet - 0.15 mg

CATAPRES- clonidine hydrochloride tablet United States - English - NLM (National Library of Medicine)

catapres- clonidine hydrochloride tablet

boehringer ingelheim pharmaceuticals inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 0.100 mg - catapres tablets are indicated in the treatment of hypertension. catapres tablets may be employed alone or concomitantly with other antihypertensive agents. catapres® (clonidine hydrochloride, usp) tablets should not be used in patients with known hypersensitivity to clonidine (see precautions ).

CATAPRES-TTS-1- clonidine transdermal system patch
CATAPRES-TTS-2- clonidine transdermal system patch
CATAPRES-TTS-3- clonidin United States - English - NLM (National Library of Medicine)

catapres-tts-1- clonidine transdermal system patch catapres-tts-2- clonidine transdermal system patch catapres-tts-3- clonidin

technomed inc. - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - catapres‑tts® is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. catapres‑tts®  should not be used in patients with known hypersensitivity to clonidine or to any other component of the transdermal system.

Dixarit 25microgram tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dixarit 25microgram tablets

boehringer ingelheim ltd - clonidine hydrochloride - oral tablet - 25microgram

Catapres-TTS New Zealand - English - Medsafe (Medicines Safety Authority)

catapres-tts

carsl consulting - clonidine 2.5mg - transdermal patch - 2.5 mg - active: clonidine 2.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

Catapres-TTS New Zealand - English - Medsafe (Medicines Safety Authority)

catapres-tts

carsl consulting - clonidine 5mg - transdermal patch - 5 mg - active: clonidine 5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.